- Home
- CVM vs ABVC Comparison
CVM vs ABVC Comparison
Compare CVM & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- ABVC
- Stock Information
- Founded
- CVM 1983
- ABVC 2015
- Country
- CVM United States
- ABVC United States
- Employees
- CVM N/A
- ABVC N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- CVM Health Care
- ABVC Health Care
- Exchange
- CVM Nasdaq
- ABVC Nasdaq
- Market Cap
- CVM 63.3M
- ABVC 52.1M
- IPO Year
- CVM 1987
- ABVC N/A
- Fundamental
- Price
- CVM $10.24
- ABVC $3.21
- Analyst Decision
- CVM
- ABVC
- Analyst Count
- CVM 0
- ABVC 0
- Target Price
- CVM N/A
- ABVC N/A
- AVG Volume (30 Days)
- CVM 138.3K
- ABVC 97.0K
- Earning Date
- CVM 08-14-2025
- ABVC 11-13-2025
- Dividend Yield
- CVM N/A
- ABVC N/A
- EPS Growth
- CVM N/A
- ABVC N/A
- EPS
- CVM N/A
- ABVC N/A
- Revenue
- CVM N/A
- ABVC $391,242.00
- Revenue This Year
- CVM N/A
- ABVC $735.18
- Revenue Next Year
- CVM N/A
- ABVC N/A
- P/E Ratio
- CVM N/A
- ABVC N/A
- Revenue Growth
- CVM N/A
- ABVC 186.84
- 52 Week Low
- CVM $1.98
- ABVC $0.40
- 52 Week High
- CVM $32.70
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- CVM 56.70
- ABVC 61.32
- Support Level
- CVM $8.69
- ABVC $2.99
- Resistance Level
- CVM $10.83
- ABVC $3.24
- Average True Range (ATR)
- CVM 0.61
- ABVC 0.18
- MACD
- CVM 0.05
- ABVC 0.02
- Stochastic Oscillator
- CVM 76.99
- ABVC 75.00
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.